Recent Biotechnology Acquisitions in Utah
Acquisition Volume in Biotechnology in Utah by Year
Last 5 years
-
August 22, 2024
- Buyer
- VION Biosciences, Iron Path Capital
- Target
- Echelon Biosciences
- Seller
- Bert V. Israelsen
- Industry
- Biotechnology
- Location
- Utah, United States
- Type
- Addon
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.
-
September 2, 2020
- Buyer
- JMD Properties, Inc.
- Target
- Stella Diagnostics, LLC
- Industry
- Biotechnology
- Location
- Utah, United States
- Type
- Buyout
JMD Properties, Inc. announced the acquisition of Stella Diagnostics, LLC via a preferred stock transaction and will change its corporate name to Stella Diagnostics, Inc. The deal positions the public company to pivot into the molecular diagnostics / biotech sector to commercialize Stella’s oncology-focused assays for esophageal disease.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.